Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Avatrombopag in thrombopoietin receptor agonist-naïve patients with immune thrombocytopenia: real-world treatment patterns and clinical outcomes from the REAL-AVA 3.0 study.
Journal: Research and practice in thrombosis and haemostasis
Published: May 06, 2026
Avatrombopag for persistent and chronic immune thrombocytopenia in children: A post hoc analysis of clinical characteristics of response from a phase 3b clinical trial.
Journal: British journal of haematology
Published: February 23, 2026
Real-world treatment patterns and outcomes among patients with immune thrombocytopenia (ITP) who switched treatment from eltrombopag or romiplostim to avatrombopag in the United States: Results from the REAL-AVA 3.5 study.
Journal: British journal of haematology
Published: January 06, 2026
Real-world avatrombopag use for immune thrombocytopenia in the United States: the REAL-AVA 2.0 multisite chart review study.
Journal: Blood vessels, thrombosis & hemostasis
Published: October 15, 2025
BPI25-014: Pacritinib in Patients With Intermediate-1 Risk Myelofibrosis: Outcomes From Post-Hoc Analysis of Two Phase 3 Studies.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
Avatrombopag treatment response in patients with immune thrombocytopenia: the REAL-AVA 1.0 study.
Journal: Therapeutic advances in hematology
Published: December 23, 2022
Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia.
Journal: Research and practice in thrombosis and haemostasis
Published: November 15, 2022
Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study.
Journal: British journal of haematology
Published: November 01, 2021
Efficacy and Safety of Avatrombopag in Patients with Chronic Immune Thrombocytopenia: A Systematic Literature Review and Network Meta-Analysis.
Journal: Advances in therapy
Published: February 26, 2021
Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: May 28, 2020
Last Updated: 09/26/2026